[1]
Corballis M.C.: Evolution of cerebral asymmetry. Prog Brain Res.2019; 250:
153-178.
[2]
Corballis M.C.: Häberling I.S.: The Many Sides of Hemispheric Asymmetry:
A Selective Review and Outlook. J Int Neuropsychol Soc. 2017; 23:
710-718.
[3]
Corballis M.C.: Early signs of brain asymmetry. Trends Cogn Sci. 2013;
17: 554-555.
[4]
Schmitz J., Güntürkün O., Ocklenburg S.: Building an Asymmetrical Brain:
The Molecular Perspective. Front Psychol. 2019; 10: 982.
[5]
Tan A.P., Wong Y.L.J., Lin B.J., et al.: Clinico-radiological approach to
cerebral hemiatrophy. Childs Nerv Syst. 2018; 34: 2377-2390.
[6]
Phi J.H., Cho B.K., Kim S.K., et al.: Germinomas in the basal ganglia:
magnetic resonance imaging classification and the prognosis. J of
Neurooncology. 2010; 99: 227-236.
[7]
Reiter E., Heim B., Scherfler C., et al.: Clinical Heterogeneity in Cerebral
Hemiatrophy Syndromes. Mov Disord Clin Pract. 2016; 3: 382-388.
[8]
D’Apolito G., Calandrelli R., Caulo M., et al.: Brain asymmetry in Newborns:
key findings, case series and literature review. Poster No.: C-1519
Congress: ECR 2015 G.
[9]
Abdul Rashid A.M., Md Noh M.S.F.: Dyke-Davidoff-Masson syndrome:
a case report. BMC Neurol 2018, 18: 76.
[10]
Li Y., Zhang T., Li B., et al.: A potential cause of adolescent onset Dyke-
Davidoff-Masson syndrome: A case report. Medicine (Baltimore). 2019;
98: e18075.
[11]
El Bahri-Ben Mrad F., Mrabet H., Ben Sghaier R., et al.: Syndrome de
Dyke-Davidoff-Masson: a propos de deux observations [Dyke-Davidoff-
Masson syndrome: a report of two cases]. J Neuroradiol. 2005; 32: 50-
53.
[12]
Gajewska E., Malak R., Kroll P., et al.: Rozwój motoryczny dziewczynki
z ZDDM. Fizjoterapia polska nr 2/2013: 39-41.
[13]
Alam M, Haq M, Ali F, et al.: Dyke-Davidoff-Masson Syndrome: An
Unusual Cause of Status Epilepticus and Refractory Seizures. Journal
of the College of Physicians and Surgeons-Pakistan : JCPSP. 2018 Jun;
28: 99-101.
[14]
Pietrzak M., Kacprzak A., Mazur M., et al.: Zespół Sturge’a-Webera –
aktualne rekomendacje diagnostyczno-terapeutyczne. Neurol Dziec.
2016; 25, 50: 101-108.
[15]
Özdoğan S., Saymaz C., Yaltırık C.K., et al. Encephalocraniocutaneous
Lipomatosis: Haberland Syndrome. Am J Case Rep. 2017; 18: 1271-
1275.
[16]
Paprocka J., Jamroz E., Adamek D., et al.: Difficulties in differentiation of
Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen
syndrome. Childs Nerv Syst. 2006; 22: 409-415.
[17]
Varadkar S., Bien C.G., Kruse C.A., et al. Rasmussen’s encephalitis:
clinical features, pathobiology, and treatment advances. Lancet Neurol.
2014; 13: 195-205.
[18]
Steinborn B.[red.], Neurologia wieku rozwojowego. PZWL Warszawa 2017.
[19]
Steinborn B.[red.], Neurologia dziecięca w przypadkach klinicznych.
PZWL Warszawa 2018
[20]
Hoffman C.E., Ochi A., Snead O.C. 3rd, et al.: Rasmussen’s encephalitis:
advances in management and patient outcomes. Childs Nerv Syst.
2016; 32: 629-640.
[21]
Sethi N.K., Tenney J.R.: Child Neurology: Hemiconvulsion-hemiplegia-
epilepsy syndrome. Neurology. 2012; 79: 2367-2368.
[22]
Auvin S., Bellavoine V., Merdariu D., et al.: Hemiconvulsion-hemiplegia-
epilepsy syndrome: current understandings. Eur J Paediatr Neurol. 2012;
16: 413-421.
[23]
Itamura S., Okanishi T., Arai Y., et al.: Three Cases of Hemiconvulsion-
Hemiplegia-Epilepsy Syndrome With Focal Cortical Dysplasia Type
IIId. Front Neurol. 2019; 10: 1233.
[24]
Konovalov A.N., Kadyrov S.U., Tarasova E.M., et al.: Basal ganglia
germinomas in children. Four clinical cases and a literature review. Zh
Vopr Neirokhir Im N N Burdenko. 2016; 80: 71-82.
[25]
Wong T.T., Chen Y.W., Guo W.Y., et al.: Germinoma involving the basal
ganglia in children. Childs Nerv Syst. 2008; 24: 71-78.
[26]
Dziadkiewicz A., Białecka M., Janik P., et al.: Hemiparkinsonism-
hemiatrophy syndrome - report on two cases and review of the
literature. Neurol Neurochir Pol. 2013; 47: 387-392.
[27]
Ropper A. H, Samuels M. A., Klein J. P.: Adams and Vicor’s Priniples of
Neurology, 10th edition, Mc Graw Hill Education 2014.
[28]
Steinborn B.[red.], Standardy postępowania diagnostyczno-
terapeutycznego w schorzeniach układu nerwowego u dzieci i młodzieży,
Wydawnictwo Bifolium, Lublin 2013 p.25-35.
[29]
Shiroishi M.S., Jackson H.A., Nelson M.D. Jr, et al.: Contralateral
hemimicrencephaly in neonatal hemimegalencephaly. Pediatr Radiol.
2010; 40: 1826-1830.
[30]
Salamon N., Andres M., Chute D.J., et al.: Contralateral
hemimicrencephaly and clinical-pathological correlations in children
with hemimegalencephaly. Brain. 2006; 129: 352-365.
[31]
Flores-Sarnat L.: Hemimegalencephaly syndrome. Handb Clin Neurol.
2008; 87: 153-176.
[32]
Bulteau Ch., Oliver M.V., Fohlen M.: Hémimégalencéphalie : aspects
génétiques, cliniques et histologiques. Epilepsies. 2008; 20: 274-280.
[33]
Lindhurst M.J., Sapp J.C., Teer J.K., et al.: A mosaic activating mutation
in AKT1 associated with the Proteus syndrome. N Engl J Med. 2011;
365: 611-619.
[34]
Ogrodnik M.,Sadowski K., Jóźwiak S.: Neurological manifestations of
Proteus syndrome – review of the literature. Neurol Dziec. 2015; 24:
47-53.
[35]
Chamli A., Litaiem N.: Hypomelanosis of Ito. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2020 Jan
[36]
John P.R.: Klippel-Trenaunay Syndrome. Tech Vasc Interv Radiol. 2019;
22: 100634.
[37]
Jellouli O., Dafiri R.: Syndrome de Klippel-Trenaunay associé à une
hémimégalencéphalie [Klippel-Trenaunay syndrome associated with
hemimegalencephaly]. Arch Pediatr. 2015; 22: 71-74.
[38]
Fliciński J., Brylak J., Stański M., et al.: Klippel-Trenaunay Syndrome
follow up – case report. Neurol Dziec. 2016; 25, 51: 67-74.
[39]
Portocarrero L.K.L., Quental K.N., Samorano L.P., et al.: Tuberous sclerosis
complex: review based on new diagnostic criteria. An Bras Dermatol.
2018; 93: 323-331.
[40]
Hirbe A.C., Gutmann D.H.: Neurofibromatosis type 1: a multidisciplinary
approach to care. Lancet Neurol. 2014; 13: 834-843.
[41]
Cutting L.E., Cooper K.L., Koth C.W., et al.: Megalencephaly in
NF1: predominantly white matter contribution and mitigation by
ADHD. Neurology. 2002; 59: 1388-1394.
Scholar Google
PubMed